Rhinitis is broadly defined as inflammation of the nasal mucosa. It is a common disorder that affects up to 40% of the population.
Conditions
Interventions
Ginger extract capsule at dose of 250 mg two times a day after meal daily for 42 days,Loratadine tablet at dose of 10 mg one times a day after morning meal daily for 42 days
Experimental Drug,Experimental Drug
Sponsors
Thai Traditional Medical Knowledge Fund
Faculty of Medicine Thammasat University
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Patients have moderate allergic rhinitis (itching and nasal obstruction,watery nasal discharge,sneezing and congestion )with a minimum total nasal symptom score 5 point 2.These patients do not have respiratory disease such as tuberculosis, nasal polyps. 3.These patients do not have history of disease: heart disease, kidney disease, liver disease, epilepsy, high blood pressure and severe asthma. 4.These patients are not pregnanct or breastfeeding. 5.These patients have normal BMI and vital signs.
Exclusion criteria
Exclusion criteria: 1.Those who have taken anti-coagulant and anti-platelet aggregation medications. 2.Those who get serious side effects from Loratadine and ginger allergy. 3.Communication problems especially listening and interview.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nasal symptom 42 days total nasal symptom score ,nasal patency 42 days Acoustic rhinometry | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life 3 weeks Rhinoconjunctivitis Quality of Life Questionnaire | — |
Countries
Thailand
Contacts
Public ContactWaipoj Chanvimalueng
Department of Otolaryngology Faculty of Medicine Thammasat University
Outcome results
None listed